Inventor

SVETOMIR N. MARKOVIC

Inventor
US

Overview

23→
Patents
2021–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 23 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07KPeptides30%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
B82YSpecific uses or applications of nanostructures2%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology2%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data2%
PatentTitleYear
12,403,119Treating lymphomas202512,364,754Methods for treating VEGF-expressing cancer using preformed nanoparticle complexes comprising albumin-bound paclitaxel and bevacizumab202512,161,718Unit dose of a composition for treating cancer202411,971,412Polypeptide-antibody complexes and uses thereof202411,878,061Methods for improving the therapeutic index for a chemotherapeutic drug202411,872,205Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins202411,660,339Methods of treating cancer using compositions of antibodies and carrier proteins with antibody pretreatment202311,655,301Carrier-binding agent compositions and methods of making and using the same202311,648,311Cancer treatments202311,590,098Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins202311,571,469Methods of treating cancer with interferon wherein the cancer cells are HLA negative or have reduced HLA expression202311,548,946Carrier-PD-L1 binding agent compositions for treating cancers202311,531,030Polypeptide-antibody complexes and uses thereof202211,439,684Lymphocyte and monocyte populations in cancer patients and autologous stem cell preparations, and uses thereof202211,433,023Albumin-PD-1 paclitaxel nanoparticle complex compositions and methods of making and using the same202211,427,637Methods of treating PD-L1 expressing cancer202211,351,254Hematologic cancer treatments202211,311,631Paclitaxel-albumin-binding agent compositions and methods for using and making the same202211,305,020Methods for reducing toxicity of a chemotherapeutic drug202211,285,221Treating myelomas202211,257,567Modeling of systematic immunity in patients202211,241,387Carrier-binding agent compositions and methods of making and using the same202211,160,876Methods and compositions for targeting t-cell cancers2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2025Patents assigned to MAYO FOUND MEDICAL EDUCATION & RES (23)· patent assignee history
2021–2025Based in US· patent location history
2022Patents assigned to FRISCH HAROLD P (1)· patent assignee history
2022Patents assigned to TURNER JAMES D (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MAYO FOUND MEDICAL EDUCATION & RES232021–2025
FRISCH HAROLD P12022
TURNER JAMES D12022
Locations
LocationPatentsSpan
US232021–2025